American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Mereo BioPharma Group (NASDAQ:MREO) Stock Rating Reaffirmed by Cantor Fitzgerald

Mereo BioPharma Group (NASDAQ:MREO) Stock Rating Reaffirmed by Cantor Fitzgerald

Cantor Fitzgerald reissued their overweight rating on shares of Mereo BioPharma Group (NASDAQ:MREO – Free Report) in a report released on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $7.00 target price... More of this article »
Image about UBS Group Trims MarketWise (NASDAQ:MKTW) Target Price to $2.00

UBS Group Trims MarketWise (NASDAQ:MKTW) Target Price to $2.00

MarketWise (NASDAQ:MKTW – Free Report) had its price target decreased by UBS Group from $3.50 to $2.00 in a report released on Thursday morning, Benzinga reports. UBS Group currently has a neutral rating on the newsletter publisher’s... More of this article »
Image about Metagenomi (NASDAQ:MGX) Receives Buy Rating from Chardan Capital

Metagenomi (NASDAQ:MGX) Receives Buy Rating from Chardan Capital

Chardan Capital restated their buy rating on shares of Metagenomi (NASDAQ:MGX – Free Report) in a research report released on Thursday, Benzinga reports. Chardan Capital currently has a $21.00 price target on the stock. A number... More of this article »
Image about Lands’ End (NASDAQ:LE) Rating Increased to Buy at Craig Hallum

Lands’ End (NASDAQ:LE) Rating Increased to Buy at Craig Hallum

Craig Hallum upgraded shares of Lands’ End (NASDAQ:LE – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday morning, MarketBeat Ratings reports. The brokerage currently has... More of this article »
Image about Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded to “Sell” by StockNews.com

Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded to “Sell” by StockNews.com

StockNews.com upgraded shares of Madrigal Pharmaceuticals (NASDAQ:MDGL – Free Report) to a sell rating in a research report sent to investors on Thursday morning. A number of other research analysts have also issued reports on... More of this article »
Image about Limbach (NASDAQ:LMB) Upgraded by StockNews.com to Strong-Buy

Limbach (NASDAQ:LMB) Upgraded by StockNews.com to Strong-Buy

StockNews.com upgraded shares of Limbach (NASDAQ:LMB – Free Report) from a buy rating to a strong-buy rating in a report released on Thursday morning. Limbach Price Performance Limbach stock opened at $41.42 on Thursday. Limbach... More of this article »
Image about Jasper Therapeutics (NASDAQ:JSPR) Earns Outperform Rating from Analysts at Royal Bank of Canada

Jasper Therapeutics (NASDAQ:JSPR) Earns Outperform Rating from Analysts at Royal Bank of Canada

Royal Bank of Canada assumed coverage on shares of Jasper Therapeutics (NASDAQ:JSPR – Free Report) in a research report report published on Thursday morning, MarketBeat Ratings reports. The firm issued an outperform rating and... More of this article »
Image about Iris Energy (NASDAQ:IREN) Receives Overweight Rating from Cantor Fitzgerald

Iris Energy (NASDAQ:IREN) Receives Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Iris Energy (NASDAQ:IREN – Free Report) in a report published on Thursday, Benzinga reports. Cantor Fitzgerald currently has a $10.00 price target on the stock. Several... More of this article »
Image about Canaccord Genuity Group Reaffirms Buy Rating for Hut 8 (NASDAQ:HUT)

Canaccord Genuity Group Reaffirms Buy Rating for Hut 8 (NASDAQ:HUT)

Canaccord Genuity Group reissued their buy rating on shares of Hut 8 (NASDAQ:HUT – Free Report) in a research note issued to investors on Thursday, Benzinga reports. Canaccord Genuity Group currently has a $3.50 target price... More of this article »
Image about Robinhood Markets (NASDAQ:HOOD) Receives Market Outperform Rating from JMP Securities

Robinhood Markets (NASDAQ:HOOD) Receives Market Outperform Rating from JMP Securities

JMP Securities reiterated their market outperform rating on shares of Robinhood Markets (NASDAQ:HOOD – Free Report) in a report issued on Thursday, Benzinga reports. They currently have a $25.00 price target on the stock. Other... More of this article »
Image about Hut 8 (NASDAQ:HUT) Given New $9.00 Price Target at HC Wainwright

Hut 8 (NASDAQ:HUT) Given New $9.00 Price Target at HC Wainwright

Hut 8 (NASDAQ:HUT – Free Report) had its price objective hoisted by HC Wainwright from $7.00 to $9.00 in a research note released on Thursday morning, Benzinga reports. HC Wainwright currently has a sell rating on the stock. HUT... More of this article »
Image about Canaccord Genuity Group Reaffirms “Buy” Rating for HIVE Digital Technologies (NASDAQ:HIVE)

Canaccord Genuity Group Reaffirms “Buy” Rating for HIVE Digital Technologies (NASDAQ:HIVE)

Canaccord Genuity Group reiterated their buy rating on shares of HIVE Digital Technologies (NASDAQ:HIVE – Free Report) in a report issued on Thursday morning, Benzinga reports. The brokerage currently has a $6.00 target price... More of this article »
Image about GDS (NASDAQ:GDS) PT Lowered to $7.00 at JPMorgan Chase & Co.

GDS (NASDAQ:GDS) PT Lowered to $7.00 at JPMorgan Chase & Co.

GDS (NASDAQ:GDS – Free Report) had its price target lowered by JPMorgan Chase & Co. from $12.00 to $7.00 in a research report sent to investors on Thursday, Benzinga reports. The brokerage currently has a neutral rating... More of this article »
Image about HC Wainwright Reiterates “Buy” Rating for Erasca (NASDAQ:ERAS)

HC Wainwright Reiterates “Buy” Rating for Erasca (NASDAQ:ERAS)

HC Wainwright restated their buy rating on shares of Erasca (NASDAQ:ERAS – Free Report) in a report published on Thursday morning, Benzinga reports. HC Wainwright currently has a $8.00 target price on the stock. A number of... More of this article »
Image about enGene (NASDAQ:ENGN) Now Covered by UBS Group

enGene (NASDAQ:ENGN) Now Covered by UBS Group

UBS Group assumed coverage on shares of enGene (NASDAQ:ENGN – Free Report) in a research note published on Thursday morning, Marketbeat reports. The firm issued a buy rating and a $37.00 target price on the stock. Several other... More of this article »